Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Correction for Kricka, Clin Chem 45 (7) 942-956.
Clinical Chemistry 46: 1722-a, 2000;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
(Clinical Chemistry. 2000;46:1722.)
© 2000 American Association for Clinical Chemistry, Inc.

Correction



The review article by L. Kricka on anti-animal antibodies entitled "Human Anti-Animal Antibody Interference in Immunological Assays" (Clin Chem 1999;45:942–56) stated that the Scantibodies Laboratories HBR product is a "monoclonal mouse anti-human IgM". Dr. Kricka indicates that a more correct characterization of this reagent is "the active blocker in HBR is a monoclonal antibody specific against a unique variable region of heterophilic antibodies, which is effective as a blocker in infectious disease and other tests".





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS